Real-World Efficacy and Safety of Thoracic Radiotherapy after First-Line Chemo-Immunotherapy in Extensive-Stage Small-Cell Lung Cancer

(1) Background: At present, the efficacy and safety of thoracic radiotherapy (TRT) after chemo-immunotherapy (CT-IT) in patients with extensive-stage small-cell lung cancer (ES-SCLC) still remain unclear. The purpose of this study was to evaluate the role of TRT after CT-IT in patients with ES-SCLC....

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Zhaoliang, Liu, Jingru, Wu, Min, Wang, Xiaohan, Lu, Yuhan, Han, Chunyan, Cong, Lei, Li, Jisheng, Meng, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253710/
https://www.ncbi.nlm.nih.gov/pubmed/37298023
http://dx.doi.org/10.3390/jcm12113828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253710/
https://www.ncbi.nlm.nih.gov/pubmed/37298023
http://dx.doi.org/10.3390/jcm12113828

Ejemplares similares